A ribonucleoside called NHC is a promising drug against COVID-19. It was studied by a collaboration of the University of North Carolina at Chapel Hill, Emory University, Vanderbilt University, Drug Innovation Ventures at Emory (DRIVE), and the CDC. The study was published recently in Science Translational Medicine. In the study, NHC is in the form…
NHC Inhibits SARS-CoV-2 and other Coronaviruses in Human Respiratory Cells and Mice
Posted on